Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dose-Titration on the Safety and Efficacy and R108512 Tablets in Subjects With Chronic Constipation

NCT00577018 is registered in ClinicalTrials.gov with Movetis as lead sponsor.

NCT NCT00577018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00577018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dose-Titration on the Safety and Efficacy and R108512 Tablets in Subjects With Chronic Constipation
Lead sponsor
Movetis
Phase
Phase 3
Overall status
Completed
Start date
August 31, 1998
Completion date
September 30, 1999
Enrollment
755 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

constipation